Stockscreener 앱 받기
16.60
1.95%
-0.33
시장 영업 전:
16.51
-0.09
-0.54%
전일 마감가:
$16.93
열려 있는:
$17.15
하루 거래량:
1.32M
Relative Volume:
1.25
시가총액:
$1.72B
수익:
$71.78M
순이익/손실:
$-295.28M
주가수익비율:
-5.2537
EPS:
-3.1597
순현금흐름:
$-271.85M
1주 성능:
-2.81%
1개월 성능:
+7.03%
6개월 성능:
+33.28%
1년 성능:
+51.74%
1일 변동 폭
$16.06
$17.39
1주일 범위
$16.06
$17.39
52주 변동 폭
$8.195
$22.50
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1600 SIERRA POINT PKWY, BRISBANE
Compare NRIX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
16.60 | 1.75B | 71.78M | -295.28M | -271.85M | -3.1597 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-24 | 재개 | Truist | Buy |
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Market Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | Jefferies | Buy |
| 2024-09-06 | 재개 | Robert W. Baird | Outperform |
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
Houte Hans Van Sells 14,055 Shares of Nurix Therapeutics (NASDAQ:NRIX) Stock - MarketBeat
Nurix CFO Hans van Houte sells $233k in company stock - Investing.com
Nurix Therapeutics (NRIX) CFO sells 14,055 shares in planned trade - Stock Titan
Insider Sell: Christine Ring Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
[144] Nurix Therapeutics, Inc. SEC Filing - Stock Titan
Nurix Therapeutics chief legal officer sells $138k in stock - Investing.com
Nurix Therapeutics (NRIX) CLO sells 8,148 shares in planned trade - Stock Titan
Form 144: Christine Ring to sell NRIX shares (NRIX) - Stock Titan
(NRIX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock - Investing.com
Nurix Therapeutics (NRIX) legal chief sells 5,394 shares in planned trade - Stock Titan
Issuer (NASDAQ: NRIX) reports proposed RSU sale by executive - Stock Titan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares By Investing.com - Investing.com Australia
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,388 Shares - MarketBeat
Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 3,214 Shares of Stock - MarketBeat
Nurix therapeutics CSO Hansen sells $53,497 common stock - Investing.com UK
Nurix therapeutics CSO Hansen sells $53,497 common stock By Investing.com - Investing.com India
Nurix therapeutics CFO Hans van Houte sells $39,748 in shares By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares - Investing.com
Nurix (NRIX) CFO nets shares after RSU vesting tax sale - Stock Titan
Tax-driven share sale and RSU vesting for Nurix (NRIX) - Stock Titan
Nurix (NRIX) CSO Hansen converts RSUs, sells 3,214 shares to cover taxes - Stock Titan
Pictet Asset Management Holding SA Acquires 1,487,060 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
California Biopharma Co. Uncovers Massive Oncology Breakthrough - Streetwise Reports
Nurix Therapeutics shares edge higher despite Q1 earnings miss - MSN
Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - MSN
Institutional Investors Accumulate Nurix Therapeutics Stock on TPD Leadership - HarianBasis.co
Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money - Insider Monkey
NRIX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $32 - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy on Nurix stock, $32 target - Investing.com UK
H.C. Wainwright reiterates Buy on Nurix stock, $32 target By Investing.com - Investing.com Australia
Billionaire Joe Edelman’s 5 Stock Picks with Huge Upside Potential - Insider Monkey
Assessing Nurix Therapeutics (NRIX) Valuation After New AACR 2026 Oncology Data - Sahm
Redmile (NRIX) holds 10.7M shares — 9.9% including warrants - Stock Titan
Nurix Therapeutics (NRIX) Receives a Buy from Piper Sandler - The Globe and Mail
Does Nurix Therapeutics (NRIX) have the potential to rally 85.84% as Wall Street analysts expect? - MSN
NRIX Reiterates by Needham -- Price Target Maintained at $26 - GuruFocus
Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):